ATOSSA THERAPEUTICS, INC.
Ownership & governance
Executives 5Directors 7Avg age 65Avg tenure 8.7y
SQ
Steven Quay
Chief Executive Officer
Age 75Since 2009-03-31Profile →
+11
Executives5
SQ
Steven Quay→
Chief Executive Officer
Age 75Since 2009-03-31
MD
Mark Daniel
Director of Finance/CFO
Age 50Since 2025-10-13
JR
Janet Rose Rea
Chief Tech/Sci/R&D Officer
—Since 2025-09-30
AM
Arezoo Mirad
Chief Tech/Sci/R&D Officer
—Since 2023-12-03
MP
Michael Parks
Investor Relations Contact
—Since 2024-08-19
Board of directors7
SQ
Steven Quay→
Chairman
Age 75Since 2009-03-31
SC
Shu-Chih Chen→
Director/Board Member
Age 64Since 2009-03-31
SG
Stephen Galli→
Director/Board Member
Age 79Since 2011-06-30
HR
Harmon Remmel→
Director/Board Member
Age 74Since 2012-01-31
RS
Richard Steinhart→
Director/Board Member
Age 68Since 2014-03-02
JF
Jonathan Finn→
Director/Board Member
Age 52Since 2023-11-07
TC
Tessa Cigler→
Director/Board Member
Age 52Since 2024-03-08
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Heights Capital Management, Inc. | 4.384 % | 377,502 |
| Vanguard Capital Management LLC | 4.054 % | 349,096 |
| Ameriprise Financial Services LLC | 2.963 % | 255,134 |
| BlackRock Institutional Trust Co. NA | 1.546 % | 133,169 |
| Renaissance Technologies LLC | 1.266 % | 109,007 |
Catalog · 2026-07-09
Registry officers13
| Name | Role | Since | Shares |
|---|---|---|---|
| Steven Quay | Chairman | 2009-03-31 | - |
| Harmon Remmel | Director/Board Member | 2012-01-31 | - |
| Heather Rees, CPA | Director or executive officer | — | 777,878 |
| Jonathan F. Finn, C.F.A | Director or executive officer | 2023-11-01 | 150,000 |
| Jonathan Finn | Director/Board Member | 2023-11-07 | - |
| Richard I. Steinhart | Director or executive officer | 2014-03-01 | 427,250 |
| Richard Steinhart | Director/Board Member | 2014-03-02 | - |
| Shu-Chih Chen | Director/Board Member | 2009-03-31 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 19Range 10–25Analysts 3
10Mean 1925
- Strong buy 1
- Buy 1
Broker actions35
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Ascendiant Capital | Maintained | Buy | 25 | 2026-10-01 |
| Rodman & Renshaw | Initiated | Buy | 12 | 2026-07-07 |
| Ascendiant Capital | Maintained | Buy | 24 | 2026-04-10 |
| HC Wainwright & Co. | Maintained | Buy | 25 | 2026-03-26 |
| Ascendiant Capital | Maintained | Buy | 8 | 2025-12-08 |
| Ascendiant Capital | Maintained | Buy | 7.75 | 2025-09-22 |
| Ascendiant Capital | Maintained | Buy | 7.5 | 2025-06-06 |
| Craig-Hallum | Initiated | Buy | 4 | 2025-06-05 |
| Ascendiant Capital | Maintained | Buy | 7.25 | 2025-04-21 |
| HC Wainwright & Co. | Reiterated | Buy | 7 | 2025-03-26 |
| HC Wainwright & Co. | Reiterated | Buy | 7 | 2025-03-12 |
| HC Wainwright & Co. | Reiterated | Buy | 7 | 2025-01-30 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.